Search results
Merck, Kelun-Biotech Ink Licensing Pact For Seven Cancer Candidates
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc (NYSE: MRK) and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical...
Merck (MRK) Inks Deal to Develop Antibodies for Treating Cancer
Zacks via Yahoo Finance· 1 year agoMerck (MRK) partners with Kelun-Biotech to develop seven antibody-drug conjugates targeting cancer...
Merck discontinues some cancer drug development with China's Sichuan Kelun
Reuters via Yahoo News· 6 months agoChinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning...
Merck (MRK) Begins Pivotal Studies on Four Cancer Candidates
Zacks via Yahoo Finance· 4 months agoMerck MRK announced the initiation of pivotal phase III studies on four of its cancer candidates,...
Merck (MRK) Beats on Q1 Earnings and Sales, Ups 2023 View
Zacks via Yahoo Finance· 1 year agoMerck MRK reported first-quarter 2023 adjusted earnings of $1.40 per share, which beat the Zacks...
Merck drops as full-year forecast misses consensus
Investing.com via Yahoo Finance· 1 year agoBy Senad Karaahmetovic and Sam Boughedda Shares of Merck&Company Inc (NYSE:MRK) tumbled more than 4% Thursday despite the New Jersey-based pharmaceutical giant reporting stronger-than-expected ...
Is Merck Stock A Buy As It Looks To Carve Share In The Cardiovascular Market?
Investor's Business Daily· 1 year agoMerck stock is lingering in a consolidation after the company unveiled promising test results for...
GSK adds to ADC dealmaking with second Chinese biotech pact
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: GSK is deepening its investment in cancer treatments called antibody-drug conjugates,...
Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints
Zacks via Yahoo Finance· 1 year agoMerck MRK reported fourth-quarter 2022 adjusted earnings of $1.62 per share, which beat the Zacks...
Merck allies with Daiichi Sankyo in major bet on antibody cancer drugs
BioPharma Dive via Yahoo Finance· 6 months agoMerck & Co. is making a major investment in the future of its cancer drug business, agreeing to one...
